Threshold of Application of Antidepressant Drugs for Treatment of Depressive Disorder

Toshihide Kuroki, Teppei Tanaka

Research output: Contribution to journalReview article

Abstract

In recent years, along with the expansion of medical care for depressive disorder, there has been much controversy regarding the application of antidepressant drugs for its treatment. The aim of this paper is to consider critical issues concerning the threshold of application of antidepressant drugs for the treatment of depression. It was formerly important to diagnose the 'quality' of depression (melancholia or non-melancholia) in order to choose antidepressant treatment, whereas an assessment of the 'quantity' of depression (severity of symptoms) is crucial today to decide on the threshold. Recent guidelines for the treatment of major depressive disorder do not positively recommend the use of medication for the treatment of mild depression. The guidelines published by the Japanese Society of Mood Disorders also state that doctors have to give priority to treatments avoiding medication, although the effectiveness of antidepressant drugs for mild depression is controversial. Actually, in a clinical setting, doctors have to understand the conditions of individual cases and cope with many issues, such as a risk of suicide, comorbidity of other psychiatric disorders, target symptoms of pharmacotherapy, and choices of classes and doses of antidepressant drugs. The threshold of application of antidepressant drugs for the treatment of depression may vary according to the doctor-patient relationship and surrounding conditions. Doctors are required to provide treatment options other than pharmacotherapy.

Original languageEnglish
Pages (from-to)269-276
Number of pages8
JournalSeishin shinkeigaku zasshi = Psychiatria et neurologia Japonica
Volume117
Issue number4
Publication statusPublished - Jan 1 2015

Fingerprint

Depressive Disorder
Antidepressive Agents
Depression
Therapeutics
Guidelines
Drug Therapy
Major Depressive Disorder
Mood Disorders
Suicide
Psychiatry
Comorbidity

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Threshold of Application of Antidepressant Drugs for Treatment of Depressive Disorder. / Kuroki, Toshihide; Tanaka, Teppei.

In: Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica, Vol. 117, No. 4, 01.01.2015, p. 269-276.

Research output: Contribution to journalReview article

@article{e20a6b4988f74df5b1a9bfd59efe9622,
title = "Threshold of Application of Antidepressant Drugs for Treatment of Depressive Disorder",
abstract = "In recent years, along with the expansion of medical care for depressive disorder, there has been much controversy regarding the application of antidepressant drugs for its treatment. The aim of this paper is to consider critical issues concerning the threshold of application of antidepressant drugs for the treatment of depression. It was formerly important to diagnose the 'quality' of depression (melancholia or non-melancholia) in order to choose antidepressant treatment, whereas an assessment of the 'quantity' of depression (severity of symptoms) is crucial today to decide on the threshold. Recent guidelines for the treatment of major depressive disorder do not positively recommend the use of medication for the treatment of mild depression. The guidelines published by the Japanese Society of Mood Disorders also state that doctors have to give priority to treatments avoiding medication, although the effectiveness of antidepressant drugs for mild depression is controversial. Actually, in a clinical setting, doctors have to understand the conditions of individual cases and cope with many issues, such as a risk of suicide, comorbidity of other psychiatric disorders, target symptoms of pharmacotherapy, and choices of classes and doses of antidepressant drugs. The threshold of application of antidepressant drugs for the treatment of depression may vary according to the doctor-patient relationship and surrounding conditions. Doctors are required to provide treatment options other than pharmacotherapy.",
author = "Toshihide Kuroki and Teppei Tanaka",
year = "2015",
month = "1",
day = "1",
language = "English",
volume = "117",
pages = "269--276",
journal = "Psychiatria et Neurologia Japonica - Seishin Shinkeigaku Zasshi",
issn = "0033-2658",
publisher = "Japanese Society of Psychiatry and Neurology",
number = "4",

}

TY - JOUR

T1 - Threshold of Application of Antidepressant Drugs for Treatment of Depressive Disorder

AU - Kuroki, Toshihide

AU - Tanaka, Teppei

PY - 2015/1/1

Y1 - 2015/1/1

N2 - In recent years, along with the expansion of medical care for depressive disorder, there has been much controversy regarding the application of antidepressant drugs for its treatment. The aim of this paper is to consider critical issues concerning the threshold of application of antidepressant drugs for the treatment of depression. It was formerly important to diagnose the 'quality' of depression (melancholia or non-melancholia) in order to choose antidepressant treatment, whereas an assessment of the 'quantity' of depression (severity of symptoms) is crucial today to decide on the threshold. Recent guidelines for the treatment of major depressive disorder do not positively recommend the use of medication for the treatment of mild depression. The guidelines published by the Japanese Society of Mood Disorders also state that doctors have to give priority to treatments avoiding medication, although the effectiveness of antidepressant drugs for mild depression is controversial. Actually, in a clinical setting, doctors have to understand the conditions of individual cases and cope with many issues, such as a risk of suicide, comorbidity of other psychiatric disorders, target symptoms of pharmacotherapy, and choices of classes and doses of antidepressant drugs. The threshold of application of antidepressant drugs for the treatment of depression may vary according to the doctor-patient relationship and surrounding conditions. Doctors are required to provide treatment options other than pharmacotherapy.

AB - In recent years, along with the expansion of medical care for depressive disorder, there has been much controversy regarding the application of antidepressant drugs for its treatment. The aim of this paper is to consider critical issues concerning the threshold of application of antidepressant drugs for the treatment of depression. It was formerly important to diagnose the 'quality' of depression (melancholia or non-melancholia) in order to choose antidepressant treatment, whereas an assessment of the 'quantity' of depression (severity of symptoms) is crucial today to decide on the threshold. Recent guidelines for the treatment of major depressive disorder do not positively recommend the use of medication for the treatment of mild depression. The guidelines published by the Japanese Society of Mood Disorders also state that doctors have to give priority to treatments avoiding medication, although the effectiveness of antidepressant drugs for mild depression is controversial. Actually, in a clinical setting, doctors have to understand the conditions of individual cases and cope with many issues, such as a risk of suicide, comorbidity of other psychiatric disorders, target symptoms of pharmacotherapy, and choices of classes and doses of antidepressant drugs. The threshold of application of antidepressant drugs for the treatment of depression may vary according to the doctor-patient relationship and surrounding conditions. Doctors are required to provide treatment options other than pharmacotherapy.

UR - http://www.scopus.com/inward/record.url?scp=84952937741&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84952937741&partnerID=8YFLogxK

M3 - Review article

C2 - 26524838

AN - SCOPUS:84952937741

VL - 117

SP - 269

EP - 276

JO - Psychiatria et Neurologia Japonica - Seishin Shinkeigaku Zasshi

JF - Psychiatria et Neurologia Japonica - Seishin Shinkeigaku Zasshi

SN - 0033-2658

IS - 4

ER -